Stock & Company Details
GT Biopharma Inc $GTBP
Price:
N/A
N/A
2.1M
$9.9M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.53
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GTBP technical indicators
Latest GT Biopharma Inc (GTBP) indicator readings as of 2026-10-29.
GTBP's 14-day RSI is 47.5, in neutral territory. At $5.60 it is trading 247.3% above its 200-day moving average of $1.61, and above its 50-day average of $5.15. Price sits in the middle of its Bollinger Bands ($4.88 to $7.47). ADX reads 26.1, indicating a trending market.
Overview
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
Finance Bot
Ask your questions
Start by typing a question below.
